| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2045 | F0371-0041 | Novel antifungal agent against Candida albicans persister cells |
|
| DCC2046 | F1386-0303 | Novel potent and selective MAP4K4 inhibitor |
|
| DCC2047 | F1414-1438 | Novel bactericidal, killing Mycobacterium tuberculosis by targeting iron-sulfur protein Rv0338c (IspQ), a putative redox sensor |
|
| DCC2048 | F1414-1444 | Novel bactericidal, killing Mycobacterium tuberculosis by targeting iron-sulfur protein Rv0338c (IspQ), a putative redox sensor |
|
| DCC2049 | F-15741 | Selective, potent inhibitor of the late current mediated by the cardiac isoform of the sodium channel (NaV1.5) |
|
| DCC2050 | F2209-0381 | Novel and potent inhibitor of PCAF catalytic domain |
|
| DCC2051 | F81-1144b | Novel matrix metalloproteinase inhibitor, reducing secretion of very low density lipoprotein-triacylglycerol, lowering TAG levels in serum and the liver, VLDL-TAG secretion, de novo FA synthesis in the liver, and serum levels of insulin and glucose |
|
| DCC2052 | Fa-613 | Novel pyrimidine synthesis inhibitor, exhibiting low micromolar antiviral activity against various influenza A and B virus strains, including the highly pathogenic influenza A strains H5N1 and H7N9, enterovirus A71, respiratory syncytial virus, human rhin |
|
| DCC2053 | Fa-alkyne | Novel clickable fumarate-competitive chemoproteomic probe |
|
| DCC2054 | Fabh Inhibitor 10 | Novel FabH Inhibitor, showing potent antibacterial activity with a MIC value of 3.89–7.81 μM−1 against the tested bacterial strains and exhibiting potent E. coli FabH inhibitory activity with an IC 50 value of 1.6 μM |
|
| DCC2055 | Fabh-in-44 | Novel inhibitor of β-ketoacyl-(acyl-carrier-protein) synthase III (FabH). |
|
| DCC2056 | Fabp4/5-in-3 | Novel FABP4/5 inhibitor, inhibiting lipolysis in 3T3-L1 adipocytes and in primary human adipocytes, reducing plasma triglyceride and free fatty acid levels, ameliorating dyslipidemia but not insulin resistance in mice with diet-induced obesity |
|
| DCC2057 | Fabp4/5-in-a16 | Novel dual inhibitor of fatty acid binding protein 4 (FABP4) and fatty acid binding protein 5 (FABP5) |
|
| DCC2058 | Fabp4/5-in-b8 | Novel dual inhibitor of fatty acid binding protein 4 (FABP4) and fatty acid binding protein 5 (FABP5) |
|
| DCC2059 | Factor Viia Inhibitor 1 | Novel factor VIIa inhibitor |
|
| DCC2060 | Factor Viia Inhibitor 2 | Novel factor VIIa inhibitor |
|
| DCC2061 | Fagaronine Chloride | Novel antileukaemic alkaloid; Inhibitor of reverse transcriptase activity of RNA-tumor viruses; Inhibitor of topoisomerase I |
|
| DCC2062 | Fa-gflg-sn38 | Novel Folate Receptor Targeting and Cathepsin B-Sensitive Drug Delivery System for Selective Cancer Cell Death and Imaging, exhibited strong cytotoxicity against FR-overexpressing SK-Hep-1, HeLa, and Siha cells, with IC50 values of 2-3 μM, but had no effe |
|
| DCC2063 | Fa-hp-ß-cyd | Novel folate-appended 2-hydroxypropyl-ß-cyclodextrin (HP-ß-CyD), showing strong anti-leukemia and cell-binding activities, inhibiting the growth of FR-expressing cells, enterjng CML cells through endocytosis and inducing both apoptosis and autophagy via m |
|
| DCC2064 | Fai-40 | Novel inhibitor of fungal fatty acid biosynthesis, demonstrating broad-spectrum activity against Candida auris and mucormycetes and retained the activity against azole-resistant candida isolates |
|
| DCC2065 | Fak Blocker A18 | Novel blocker of focal adhesion kinase (FAK) autophosphorylation |
|
| DCC2066 | Fak Degrader Fc-11 | Novel highly potent FAK-targeting PROTAC degrader, showing a rapid and reversible FAK degradation |
|
| DCC2067 | Fam-deala-hyp-yipd | Novel Fluorescent HIF-1α peptide |
|
| DCC2068 | F-amidine | Potent and bioavailable irreversible inactivator of PAD4 |
|
| DCC2069 | Famprofazone | Nonsteroidal anti-inflammatory drug (NSAID) |
|
| DCC2070 | Fanetizole Mesylate | Inhibitor of neutrophil superoxide production |
|
| DCC2071 | Fapl-fluorescein | Novel FAP-targeted Fluorescein dye conjugate |
|
| DCC2072 | Fapl-s0456 | Novel FAP-targeted NIR dye conjugate |
|
| DCC2073 | Farnesiferol C | Inducer of apoptosis via regulation of L11 and c-Myc with combinational potential with anticancer drugs in non-small-cell lung cancers |
|
| DCC2074 | Farnesylthiotriazole | Stable and persistent PKC activator |
|
